Medexus Pharmaceuticals Inc (MDP.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 03-2020 | 03-2019 | 03-2018 | 03-2017 | 03-2016 | |
| Sales | 52,432 | 25,363 | 7,751 | 4,654 | 2,889 |
| Cost of Goods | 22,990 | 10,380 | 3,847 | 2,083 | 998 |
| Gross Profit | 29,442 | 14,983 | 3,904 | 2,571 | 1,891 |
| Operating Expenses | 30,482 | 15,664 | 6,099 | 5,120 | 5,282 |
| Operating Income | -1,041 | -681 | -2,195 | -2,549 | -3,391 |
| Interest Expense | 6,442 | 2,904 | 919 | 502 | 733 |
| Other Income | 2,295 | -1,133 | 417 | 1,677 | 2,352 |
| Pre-tax Income | -5,188 | -4,719 | -2,697 | -1,374 | -1,771 |
| Income Tax | -790 | 166 | N/A | N/A | N/A |
| Net Income Continuous | -4,397 | -4,885 | -2,697 | -1,374 | -1,771 |
| Net Income | $-4,397 | $-4,885 | $-2,697 | $-1,374 | $-1,771 |
| EPS Basic Total Ops | -0.30 | -0.49 | -0.48 | -0.28 | -0.35 |
| EPS Basic Continuous Ops | -0.30 | -0.49 | -0.48 | -0.28 | -0.35 |
| EPS Diluted Total Ops | -0.30 | -0.49 | -0.48 | -0.28 | -0.35 |
| EPS Diluted Continuous Ops | -0.30 | -0.49 | -0.48 | -0.28 | -0.35 |
| EBITDA(a) | $4,961 | $119 | $-1,599 | $-833 | $-925 |